| 1 |
Yang L, Wang F, Ren P, Zhang T, Zhang Q. Poly(2-oxazoline)s: synthesis and biomedical applications. Macromol Res 2023. [DOI: 10.1007/s13233-023-00116-x] [Reference Citation Analysis]
|
| 2 |
Romanini M, Pérez Valmaseda A, Macovez R. Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.122390] [Reference Citation Analysis]
|
| 3 |
Haider MS, Mahato AK, Kotliarova A, Forster S, Böttcher B, Stahlhut P, Sidorova Y, Luxenhofer R. Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration. Biomacromolecules 2022. [PMID: 36219820 DOI: 10.1021/acs.biomac.2c00761] [Reference Citation Analysis]
|
| 4 |
Langer C, Köll-weber M, Holzer M, Hantel C, Süss R. Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids. Pharmaceutics 2022;14:1891. [DOI: 10.3390/pharmaceutics14091891] [Reference Citation Analysis]
|
| 5 |
Bornstein S, Shapiro I, Malyukov M, Züllig R, Luca E, Gelfgat E, Beuschlein F, Nölting S, Berruti A, Sigala S, Peitzsch M, Steenblock C, Ludwig B, Kugelmeier P, Hantel C. Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin. Cell Death Dis 2022;13:648. [PMID: 35879289 DOI: 10.1038/s41419-022-05096-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Bornstein S, Shapiro I, Malyukov M, Züllig R, Luca E, Gelfgat E, Beuschlein F, Nölting S, Berruti A, Sigala S, Peitzsch M, Steenblock C, Ludwig B, Kugelmeier P, Hantel C. Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.. [DOI: 10.1101/2022.01.10.475686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Haider MS, Ahmad T, Yang M, Hu C, Hahn L, Stahlhut P, Groll J, Luxenhofer R. Tuning the Thermogelation and Rheology of Poly(2-Oxazoline)/Poly(2-Oxazine)s Based Thermosensitive Hydrogels for 3D Bioprinting. Gels 2021;7:78. [PMID: 34202652 DOI: 10.3390/gels7030078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Steenaard RV, Ettaieb MHT, Kerkhofs TMA, Haak HR. How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives. Expert Opin Drug Metab Toxicol 2021;17:677-83. [PMID: 33886381 DOI: 10.1080/17425255.2021.1921146] [Reference Citation Analysis]
|
| 9 |
Zahoranová A, Luxenhofer R. Poly(2-oxazoline)- and Poly(2-oxazine)-Based Self-Assemblies, Polyplexes, and Drug Nanoformulations-An Update. Adv Healthc Mater 2021;10:e2001382. [PMID: 33448122 DOI: 10.1002/adhm.202001382] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 10 |
Corso CR, Acco A, Bach C, Bonatto SJR, de Figueiredo BC, de Souza LM. Pharmacological profile and effects of mitotane in adrenocortical carcinoma. Br J Clin Pharmacol 2021;87:2698-710. [PMID: 33382119 DOI: 10.1111/bcp.14721] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 11 |
Haider MS, Lübtow MM, Endres S, Forster S, Flegler VJ, Böttcher B, Aseyev V, Pöppler A, Luxenhofer R. Think Beyond the Core: Impact of the Hydrophilic Corona on Drug Solubilization Using Polymer Micelles. ACS Appl Mater Interfaces 2020;12:24531-43. [DOI: 10.1021/acsami.9b22495] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 12 |
Lübtow MM, Oerter S, Quader S, Jeanclos E, Cubukova A, Krafft M, Haider MS, Schulte C, Meier L, Rist M, Sampetrean O, Kinoh H, Gohla A, Kataoka K, Appelt-menzel A, Luxenhofer R. In Vitro Blood–Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D Models. Mol Pharmaceutics 2020;17:1835-47. [DOI: 10.1021/acs.molpharmaceut.9b01117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
